Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer Builds On Oncology Pipeline With Nycomed’s Divested Kinase Inhibitors

This article was originally published in The Pink Sheet Daily

Executive Summary

Acquisition of two candidates and back-up compounds complements ongoing Nexavar efforts, Bayer says.

You may also be interested in...



Bayer Beefs Up Biologics Pipeline With Direvo Biotech Buy

Separate spin-out transaction establishes Direvo’s industrial biotech business as an independent entity.

Bayer Beefs Up Biologics Pipeline With Direvo Biotech Buy

Separate spin-out transaction establishes Direvo’s industrial biotech business as an independent entity.

Maxygen Gets $90 Million Cash Infusion From Bayer For Hemophilia Program

Deal will build on Bayer’s hemophilia experience with Kogenate, and provide cash for Maxygen to explore autoimmune programs.

Related Content

Topics

UsernamePublicRestriction

Register

PS068313

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel